Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 28, 2018; 24(28): 3155-3162
Published online Jul 28, 2018. doi: 10.3748/wjg.v24.i28.3155
Published online Jul 28, 2018. doi: 10.3748/wjg.v24.i28.3155
Table 2 Adverse events according to Common Toxicity Criteria for Adverse Events v4.0 n (%)
| Adverse events | Grade 1 | Grade 2 | Grade 3 | All |
| MKI-associated HFSR | 11 (27) | 6 (15) | 5 (13) | 22 (55) |
| Anemia | 10 (25) | 4 (10) | 0 (0) | 14 (35) |
| Hypertension | 7 (17) | 5 (13) | 0 (0) | 12 (30) |
| Anorexia | 7 (17) | 4 (10) | 1 (3) | 12 (30) |
| Decreased platelet count | 4 (10) | 4 (10) | 4 (10) | 12 (30) |
| Alopecia | 9 (22) | 1 (3) | 0 (0) | 10 (25) |
| Diarrhea | 5 (13) | 0 (0) | 2 (4) | 7 (17) |
- Citation: Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2018; 24(28): 3155-3162
- URL: https://www.wjgnet.com/1007-9327/full/v24/i28/3155.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i28.3155